Enterprise Financial Services Corp Taro Pharmaceutical Industries LTD Transaction History

Enterprise Financial Services Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$43.12 - $50.3 $17,679 - $20,623	-410 Closed	0 $0
Q1 2019 Apr 26, 2019	BUY	$85.97 - $108.09 $35,247 - $44,316	410 New	410 $44,000
Q1 2018 Apr 27, 2018	SELL	$95.91 - $107.26 $4,220 - $4,719	-44 Closed	0 $0
Q3 2017 Oct 27, 2017	BUY	$97.26 - $116.2 $4,279 - $5,112	44	44 $5,000

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

Stay updated on Enterprise Financial Services Corp with notifications on news.